A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yin, Chao
Marshall, John
Macke, Laura Ann
He, Aiwu Ruth
Bouker, Kerrie
Weinberg, Benjamin Adam
Mukherji, Reetu
Weiner, Louis M.
Wang, Hongkun
Geng, Xue
Hoke, Frank
Youssoufian, Hagop
El-Hariry, Iman
Noel, Marcus Smith
机构：
[1] Virginia Canc Specialists, Fairfax, VA USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Ctr Cure Gastrointestinal Canc, Washington, DC USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[4] Georgetown Univ, Lombardi Comprehens Canc Ctr, Div Hematol & Oncol, Washington, DC USA
[5] Georgetown Univ, Med Ctr, Washington, DC USA
[6] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[7] Georgetown Univ, Dept Biostat Bioinformat & Biomathemat, Washington, DC USA
[8] Erytech Pharma Inc, Cambridge, MA USA
[9] Brown Univ, Providence, RI USA
[10] Erytech Pharma Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16288
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I dose-escalation trial of TH-302 with nab-paclitaxel and gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma
    Olszanski, Anthony J.
    Wang-Gillam, Andrea
    Kwak, Eunice Lee
    Nazzal, Kamal
    Mehdi, Fazal
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer
    Yixing Jiang
    Heath B. Mackley
    Eric T. Kimchi
    Junjia Zhu
    Niraj Gusani
    Jussuf Kaifi
    Kevin F. Staveley-O’Carroll
    Chandra P. Belani
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 205 - 210
  • [23] Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer
    Jiang, Yixing
    Mackley, Heath B.
    Kimchi, Eric T.
    Zhu, Junjia
    Gusani, Niraj
    Kaifi, Jussuf
    Staveley-O'Carroll, Kevin F.
    Belani, Chandra P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 205 - 210
  • [24] FOLFIRINOX chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma: A retrospective analysis of toxicity and outcomes
    Kerr, Ashleigh
    Grose, Derek B.
    Hall, Sally
    McIntosh, David
    MacLaren, Vivienne
    Ali, Clinton
    Hennessy, Aisling
    McDonald, Alexander
    Graham, Janet Shirley
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [25] FOLFIRINOX FOR LOCALLY ADVANCED OR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDA); CLINICAL OUTCOMES AND PROGNOSTIC FACTORS, THE ROYAL MARSDEN (RM) EXPERIENCE
    Yu, Moorcraft Sing
    Khurum, Khan
    Clare, Peckitt
    David, Watkins
    Sheela, Rao
    David, Cunningham
    Ian, Chau
    ANNALS OF ONCOLOGY, 2014, 25 : 78 - 78
  • [26] Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma
    Klute, Kelsey
    Picozzi, Vincent J.
    Gabrail, Nashat
    Hollingsworth, Michael A.
    McAleer, Christopher
    Young, Diane
    Strayer, David Rodney
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
    Yaman Suleiman
    Amit Mahipal
    David Shibata
    Erin M. Siegel
    Helen Jump
    William J. Fulp
    Gregory M. Springett
    Richard Kim
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
  • [28] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    PLOS ONE, 2015, 10 (04):
  • [29] A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
    Chang, Chen
    Li, Xiaofen
    Cheng, Ke
    Cai, Zhaolun
    Xiong, Junjie
    Lv, Wanrui
    Li, Ruizhen
    Zhang, Pei
    Cao, Dan
    ONCOLOGIST, 2023, 28 (07): : E575 - E584
  • [30] A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma ( PDAC)
    Cecchini, Michael
    Salem, Ronald
    Robert, Marie
    Czerniak, Suzanne
    Rajaei, Moein
    Townsend, Jeffrey
    Blaha, Ondrej
    Zelterman, Daniel
    Thumar, Jaykumar
    Kortmansky, Jeremy
    Zaheer, Wajih
    Fischbach, Neal
    Persico, Justin
    Stein, Stacey
    Khan, Sajid
    Cha, Charles
    Billingsley, Kevin
    Kunstman, John
    Chowdhury, Sumedha
    Tseng, Robert
    Mauricio, Carlos
    Yugawa, Deanne
    Escobar-Hoyos, Luisa
    Johung, Kimberly
    Wiess, Christina
    Spickard, Erik
    Aushev, Vasily N.
    Laliotis, George
    Jurdi, Adham
    Liu, Minetta C.
    Lacy, Jill
    CANCER RESEARCH, 2024, 84 (02)
12345